The Last Gift Programme: A New Approach to Medical Research
At the University of California, San Diego (UCSD), a groundbreaking initiative known as Last Gift is redefining the way terminally ill patients contribute to medical research. This program allows individuals facing life-limiting conditions to play an active role in developing more effective treatments. By participating in clinical studies, these patients help shift the traditional risk-benefit analysis that typically applies to healthy individuals. Researchers can engage them in ways that would not be possible with people who have a longer life expectancy, and many terminally ill patients are willing to take part in studies that others might avoid.
Shifting Focus from Animal Testing
In recent years, major U.S. research agencies, including the Food and Drug Administration (FDA) and the National Institutes of Health (NIH), have emphasized the need to move away from animal testing. They now recognize that results from such tests often do not accurately predict human responses. Terminally ill patients can offer their own bodies to support this shift toward more human-relevant research. Their participation generates valuable data on how humans respond to new treatments, while also reducing the suffering of laboratory animals.
Surveying Patient Willingness
Before launching the Last Gift programme, UCSD researchers surveyed nearly 500 individuals about their willingness to participate in end-of-life medical research. More than half of those surveyed said they would be willing to give up four weeks of their life to take part in research, even if they had only six months left. Over a third expressed interest in being exposed to pathogens such as streptococcus bacteria, hepatitis C virus, or malaria to help develop new treatments and vaccines.
Many participants, especially those receiving hospice care, described a strong desire to “give back.” For them, contributing to science provided a deeper sense of purpose during their final days.
Focusing on HIV Research
Currently, the Last Gift programme is centered on understanding where HIV hides in the body. Participants in this study are infected with HIV and are also terminally ill. Unlike traditional research that relies on post-mortem donations, these individuals actively participate in invasive procedures while still alive, including biopsies, spinal taps, and blood draws.
Davey Smith, the lead investigator for the Last Gift study at UCSD, has been deeply moved by the willingness of participants to contribute their time, energy, and even their bodies to science. He notes, “It is incredible how much our study participants want to give of their time, energy, and literal body to science. They are pushing hard for us to do more, faster.”
Expanding the Scope of Research
The programme is not limited to research directly related to a participant’s illness. For example, someone with advanced cancer might volunteer for a trial involving a vaccine for an infectious viral disease. This trial would involve deliberate exposure to the virus to test whether the vaccine offers protection.
Such flexibility allows participants to choose which diseases or medical conditions matter most to them. This approach restores a sense of agency to individuals near the end of life and integrates them into a broader effort to improve human health.
Real-Life Impact
In May 2023, Richard Scolyer, an Australian melanoma specialist, was diagnosed with glioblastoma, an aggressive brain tumour. Patients with this condition typically have a short life expectancy. Despite his diagnosis, Scolyer chose to become “patient zero” in an experimental immunotherapy trial using a treatment proven in melanoma but never before tested in glioblastoma. “The data that we’ve generated,” he said, “I know it’s changing the field, and if I die tomorrow with that, I’m very proud.”
The Broader Implications
Medical research does not require one to be a scientist to make a meaningful contribution. Many patients can help develop safer drugs for curing human diseases while also reducing the reliance on animals in research. Collaborations between researchers and terminally ill patients have the potential to save lives and add meaning to the final days of those who are dying.
Initiatives like Last Gift demonstrate that when individuals face the end of life, they can still make a significant impact on the future of medicine. These programmes benefit not only humans but also all sentient beings, offering hope and purpose in the face of mortality.
